These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15908727

  • 1. [Modern trends in the treatment of patients with atrial fibrillation].
    Abuladze G, Mamamtavrishvili N, Jashi I, Kantaria D, Ambroladze N.
    Georgian Med News; 2005 Apr; (121):59-61. PubMed ID: 15908727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modern concepts of atrial fibrillation.
    Chun JG, Brodsky MA, Allen BJ.
    Herz; 1993 Feb; 18(1):67-75. PubMed ID: 8454254
    [Abstract] [Full Text] [Related]

  • 5. Management of atrial fibrillation.
    Hersi A, Wyse DG.
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS.
    Cardiol Rev; 2008 Apr; 16(4):181-8. PubMed ID: 18562808
    [Abstract] [Full Text] [Related]

  • 8. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [Abstract] [Full Text] [Related]

  • 9. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
    Kosior DA, Stawicki S, Wozakowska-Kapłon B, Szulc M, Opolski G, Rabczenko D.
    Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
    [Abstract] [Full Text] [Related]

  • 10. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P, Fetsch T, Hanrath P, Meinertz T, Steinbeck G, Lehmacher W, Breithardt G.
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [Abstract] [Full Text] [Related]

  • 11. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS.
    Cardiol Rev; 2008 Nov; 16(5):230-9. PubMed ID: 18708824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators.
    Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M, Tanaka K, Kato T, Morita N, Sato N, Yasutake M, Kobayashi Y, Takano T.
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation.
    Holmqvist F, Stridh M, Waktare JE, Sörnmo L, Olsson SB, Meurling CJ.
    Eur Heart J; 2006 Sep; 27(18):2201-7. PubMed ID: 16956916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.